Immutep Limited (IMMP) Financials

IMMP Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 57.6 million 15.0 million
March 31, 2026 ? ?
Dec. 31, 2025 98.3 million 32.3 million
June 30, 2025 103.2 million 8.8 million

IMMP Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -20.2 million ?
March 31, 2026 9.3 million ?
Dec. 31, 2025 -18.8 million ?
June 30, 2025 -22.1 million 765161

IMMP Net Income

No data available :(

IMMP Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 47.6 million - 523523
March 31, 2026 - - -
Dec. 31, 2025 66.2 million - 807932
June 30, 2025 85.3 million - 342158

IMMP Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 101.9 million
March 31, 2026 ?
Dec. 31, 2025 98.2 million
June 30, 2025 95.9 million

IMMP Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 4562 - 33.9 million -
March 31, 2026 3425 - - -
Dec. 31, 2025 60755 - 3.6 million -
June 30, 2025 22535 23.7 million 2.9 million -

IMMP Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.3 million 742775
March 31, 2026 - -
Dec. 31, 2025 4.0 million 31.1 million
June 30, 2025 1.2 million 23.7 million

IMMP

Price: $3.17

52 week price:
3.17
70.60

Earnings Per Share: -0.39 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 112316

Market Capitalization: 32.1 million

Links: